Inactivation of hTERT transcription by Tax

被引:68
作者
Gabet, AS
Mortreux, F
Charneau, P
Riou, P
Duc-Dodon, M
Wu, YL
Jeang, KT
Wattel, E
机构
[1] Ctr Leon Berard, CNRS UMR 5537, Unite Oncogenese Viral, F-69373 Lyon 08, France
[2] Inst Pasteur, Grp Virol Mol & Vector, F-75724 Paris, France
[3] Fac Med Lyon Laennec, CNRS UMR 5537, F-69372 Lyon 8, France
[4] NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA
[5] Hop Edouard Herriot, Hematol Serv, F-69437 Lyon 03, France
关键词
telomere; telomerase HTLV-1 hTERT oncogene; oncogenegic leukemogenesis;
D O I
10.1038/sj.onc.1206468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomerase expression is the hallmark of tumor cells in which this ribonucleoprotein complex preserves chromosome integrity by maintaining telomere length and thereby prevents cell death. However, recent data support a role of the combination of p53 and telomerase inactivation in initiating genetic instability that promotes malignant transformation. Through its pleiotropic effects on infected T-cell metabolism, the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax plays a central role in leukemogenesis. Here, we show that Tax inhibits human telomerase reverse transcriptase (hTERT) transcription, which is the rate-limiting factor of telomerase activity. This inhibitory effect, that occurs in competition with c-Myc through a canonical c-Myc binding site within the hTERT promoter, results in a decreased telomerase activity of Tax-expressing cells. This is the first demonstration of hTERT inhibition by an oncogene. Tax, which is only expressed in preleukemic cells, triggers infected T-cell cycle and keeps these cells cycling while inactivating p53. We propose that, in combination with these effects, h TER T repression by Tax at an early phase of carcinogenesis might contribute to the massive ploidy changes associated with the development of HTLV-1-associated malignancies.
引用
收藏
页码:3734 / 3741
页数:8
相关论文
共 61 条
[1]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[2]   A critical role for telomeres in suppressing and facilitating carcinogenesis [J].
Artandi, SE ;
DePinho, RA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :39-46
[3]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[4]  
Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO
[5]  
2-L
[6]   Persistent oligoclonal expansion of human T-cell leukemia virus type 1 infected circulating cells in patients with Tropical spastic paraparesis HTLV-1 associated myelopathy [J].
Cavrois, M ;
Leclercq, I ;
Gout, O ;
Gessain, A ;
Wain-Hobson, S ;
Wattel, E .
ONCOGENE, 1998, 17 (01) :77-82
[7]  
CESARMAN E, 1992, BLOOD, V80, P3205
[8]   TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY [J].
COUNTER, CM ;
AVILION, AA ;
LEFEUVRE, CE ;
STEWART, NG ;
GREIDER, CW ;
HARLEY, CB ;
BACCHETTI, S .
EMBO JOURNAL, 1992, 11 (05) :1921-1929
[9]   E2F-1 represses transcription of the human telomerase reverse transcriptase gene [J].
Crowe, DL ;
Nguyen, DC ;
Tsang, KJ ;
Kyo, S .
NUCLEIC ACIDS RESEARCH, 2001, 29 (13) :2789-2794
[10]   For better or worse? Telomerase inhibition and cancer [J].
de Lange, T ;
Jacks, T .
CELL, 1999, 98 (03) :273-275